Volpara Health Technologies Proprietà degli esecutivi
Cos'è Proprietà degli esecutivi di Volpara Health Technologies?
Proprietà degli esecutivi di Volpara Health Technologies Limited è 24.90%
Qual è la definizione di Proprietà degli esecutivi?
La proprietà degli esecutivi (Insider Ownership) è calcolata come il numero totale di azioni possedute dagli esecutivi (azionisti che detengono più del 5% della società o un funzionario o direttore della società) diviso per il totale delle Azioni in circolazione.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Proprietà degli esecutivi di aziende nel Health Care settore su ASX rispetto a Volpara Health Technologies
Cosa fa Volpara Health Technologies?
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Aziende con proprietà degli esecutivi simili a Volpara Health Technologies
- IG Design Plc ha Proprietà degli esecutivi di 24.88%
- Science plc ha Proprietà degli esecutivi di 24.88%
- ValOre Metals ha Proprietà degli esecutivi di 24.89%
- Spectra Systems ha Proprietà degli esecutivi di 24.89%
- Firstwave Cloud Technology ha Proprietà degli esecutivi di 24.90%
- Surface Transforms Plc ha Proprietà degli esecutivi di 24.90%
- Volpara Health Technologies ha Proprietà degli esecutivi di 24.90%
- Supernova Partners Acquisition ha Proprietà degli esecutivi di 24.90%
- Kogan.Com ha Proprietà degli esecutivi di 24.90%
- Reckon ha Proprietà degli esecutivi di 24.91%
- Golden Ridge Resources ha Proprietà degli esecutivi di 24.91%
- China Strategic ha Proprietà degli esecutivi di 24.91%
- Cybernaut International ha Proprietà degli esecutivi di 24.91%